Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Insights, Forecast to 2028

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Insights, Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CINV
1.2.3 PONV
1.3 Market by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2017-2028)
2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Region
2.2.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Region (2017-2022)
2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2023-2028)
2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Dynamics
2.3.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Trends
2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
2.3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
2.3.4 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue
3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2017-2022)
3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2017-2022)
3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
3.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
3.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2021
3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
3.6 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
3.7 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2017-2022)
4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2023-2028)
5 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Application (2017-2022)
5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
6.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
6.2.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
6.2.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
6.2.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
6.3.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
6.3.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
6.3.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
6.4.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
6.4.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
7.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
7.2.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
7.3.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
7.3.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
7.3.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
7.4.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
7.4.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
8.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
8.2.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
8.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
8.3.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
8.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region
8.4.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
9.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
9.2.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
9.2.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
9.2.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
9.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
9.3.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
9.3.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
9.3.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
9.4 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
9.4.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
9.4.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
10.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
10.2.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
10.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
10.3.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
10.4 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
10.4.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.2.5 Eisai Recent Developments
11.3 ProStrakan
11.3.1 ProStrakan Company Details
11.3.2 ProStrakan Business Overview
11.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.3.5 ProStrakan Recent Developments
11.4 Helsinn Holding
11.4.1 Helsinn Holding Company Details
11.4.2 Helsinn Holding Business Overview
11.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.4.5 Helsinn Holding Recent Developments
11.5 Mundipharma
11.5.1 Mundipharma Company Details
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.5.5 Mundipharma Recent Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Details
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.6.5 Qilu Pharma Recent Developments
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.7.5 Teva Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 Heron Therapeutics
11.9.1 Heron Therapeutics Company Details
11.9.2 Heron Therapeutics Business Overview
11.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.9.5 Heron Therapeutics Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.10.5 Roche Recent Developments
11.11 Mylan
11.11.1 Mylan Company Details
11.11.2 Mylan Business Overview
11.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.11.5 Mylan Recent Developments
11.12 Tesaro
11.12.1 Tesaro Company Details
11.12.2 Tesaro Business Overview
11.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
11.12.5 Tesaro Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CINV
Table 3. Key Players of PONV
Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2017-2022)
Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2023-2028)
Table 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends
Table 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
Table 12. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
Table 13. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
Table 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players (2017-2022)
Table 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2021)
Table 17. Ranking of Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
Table 21. Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2017-2022)
Table 25. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2023-2028)
Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2017-2022)
Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2023-2028)
Table 31. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 64. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 65. Merck Recent Developments
Table 66. Eisai Company Details
Table 67. Eisai Business Overview
Table 68. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 69. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 70. Eisai Recent Developments
Table 71. ProStrakan Company Details
Table 72. ProStrakan Business Overview
Table 73. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 74. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 75. ProStrakan Recent Developments
Table 76. Helsinn Holding Company Details
Table 77. Helsinn Holding Business Overview
Table 78. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 79. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 80. Helsinn Holding Recent Developments
Table 81. Mundipharma Company Details
Table 82. Mundipharma Business Overview
Table 83. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 84. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 85. Mundipharma Recent Developments
Table 86. Qilu Pharma Company Details
Table 87. Qilu Pharma Business Overview
Table 88. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 89. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 90. Qilu Pharma Recent Developments
Table 91. Teva Company Details
Table 92. Teva Business Overview
Table 93. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 94. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 95. Teva Recent Developments
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 99. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 100. Novartis Recent Developments
Table 101. Heron Therapeutics Company Details
Table 102. Heron Therapeutics Business Overview
Table 103. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 104. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 105. Heron Therapeutics Recent Developments
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 109. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 110. Roche Recent Developments
Table 111. Mylan Company Details
Table 112. Mylan Business Overview
Table 113. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 114. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 115. Mylan Recent Developments
Table 116. Tesaro Company Details
Table 117. Tesaro Business Overview
Table 118. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 119. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
Table 120. Tesaro Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2021 VS 2028
Figure 2. CINV Features
Figure 3. PONV Features
Figure 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered
Figure 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region: 2021 VS 2028
Figure 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2021
Figure 13. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2021
Figure 15. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
Figure 17. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
Figure 18. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
Figure 19. United States Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
Figure 23. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
Figure 25. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Region (2017-2028)
Figure 35. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
Figure 45. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
Figure 51. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Merck Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure 55. Eisai Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure 56. ProStrakan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure 57. Helsinn Holding Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure 58. Mundipharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure 59. Qilu Pharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure 60. Teva Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs